================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
July 1, 2004
Date of Report (Date of earliest event reported)
-----------------
ZYMOGENETICS, INC.
(Exact name of registrant as specified in its charter)
Washington 0-33489 91-1144498
(State or other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification Number)
1201 Eastlake Avenue East
Seattle, Washington 98102-3702
(Address of principal executive offices) (Zip Code)
206-442-6600
(Registrant's telephone number, including area code)
Item 5. Other Events
On July 1, 2004, ZymoGenetics, Inc. issued a press release announcing the
appointment of James A. Harper to its Board of Directors effective July 1, 2004.
Mr. Harper is also expected to serve on the Compensation Committee of the Board
of Directors.
The press release is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits.
99.1 Press Release issued July 1, 2004 by ZymoGenetics, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
ZYMOGENETICS, INC.
Date: July 1, 2004 By: /s/ JAMES A. JOHNSON
-----------------------------------------------
Name: James A. Johnson
Title: Senior Vice President and Chief Financial Officer
EXHIBIT INDEX
Exhibit Document Description
Number
- ------- --------------------
99.1 Press release issued July 1, 2004 by ZymoGenetics, Inc.